Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib significantly improves nail and hair symptoms in severe alopecia areata.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

Epidermolysis bullosa in calves was not caused by mutations in the keratin genes bKRT5 and bKRT14.

BPH management needs better long-term studies and prevention strategies.

A bull with a gene mutation was asymptomatic, synthetic retinoids cause hair loss, and new therapeutic targets were identified for skin diseases.

Lef1 helps stem cells become hair cells by interacting with specific signaling pathways.

Male pattern baldness may predict prostate cancer risk.

Dermatologists are key in detecting and managing OCD and BFRBs by working with psychiatrists.

The B2C promoter works in sheep cells but not in mouse embryos.

The FDA approved the first gene therapy for a blood disorder after overcoming early challenges and demonstrating patient benefits.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

848 genes related to fat and metabolism are less active in people with Central Centrifugal Cicatricial Alopecia.

Mice with the ab gene have abnormal sebaceous gland development, affecting sebum production.

Baricitinib effectively promotes hair regrowth in severe alopecia with minimal side effects.